Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis.
Cellular immunity was studied in 73 patients with recurrent vaginal moniliasis and 37 healthy controls, by skin testing with the multitest CMI kit and Candida antigen, with measurement of lymphoblastic transformation to phytohemagglutinin, antigens of Candida albicans, mumps, and streptokinase. Eighteen patients (24.7%) had a hypoergic or anergic response to Candida antigen on skin testing versus two controls (5.4%), p = 0.01. Overall, the patient's lymphoblastic proliferation to mitogen and various antigens was not significantly different from that of the controls. However, a subgroup of younger women (19 to 29 years old) had impaired responses to Candida antigen when compared with age-matched controls, 58% versus 17%, p less than 0.005. Most women with current vaginal moniliasis had normal cellular immunity.
Fong
I W
IW
Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
McCleary
P
P
Read
S
S
D000328:Adult; D000946:Antigens, Fungal / Q000276:immunology; D002176:Candida albicans; D002177:Candidiasis / Q000276:immunology*; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008875:Middle Aged; D011933:Reagent Kits, Diagnostic; D012008:Recurrence; D012016:Reference Values; D012882:Skin Tests; D013234:Stem Cells / Q000276:immunology; D014623:Vaginal Diseases / Q000276:immunology*; D014845:Vulvar Diseases / Q000276:immunology*
D000946:Antigens, Fungal; D011933:Reagent Kits, Diagnostic